China: Ambitious plan to dominate global innovative drug market by 2030
China aims to capture 25% of the global first-in-class drug market by 2030.
Published 6j1 sourceImportant
Lire en français
≈ 18s
The fact
A five-year plan includes technological breakthroughs and expansion in the biomedical sector.
Beijing seeks to become a dominant leader in biopharmaceuticals.
Click the link to read an article on the topic: